New name for GSK spin-off

GSK has revealed that its consumer healthcare business will be called Haleon following its planned spin-off mid-2022, with Aussie staff set to move into brand new headquarters. 

Anish Patel, ANZ General Manager designate of Haleon said, "the creation of Haleon is an exciting milestone as we move towards our future as a new, standalone consumer healthcare company".

The new name, which was developed with input from staff, healthcare practitioners and consumers, was announced as part of a global celebration for all the people working in GSK Consumer Healthcare earlier today (Wednesday).